Resurgence of Bordetella pertussis infection.
Weir
Erica
E
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001885:Bordetella Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D001886:Bordetella pertussis; D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D021821:Communicable Diseases, Emerging / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage*; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007115:Immunization Schedule; D007223:Infant
D000900:Anti-Bacterial Agents; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D004917:Erythromycin